← Open Payments lookup

ANNMARIE REED: Open Payments

NPI 1235520842 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$904 in 18 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $510 · 2025 $904

Food & beverage: $904
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$387
E.R. Squibb & Sons, L.L.C.4$297
ABBVIE INC.5$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
Takeda Pharmaceuticals U.S.A., Inc.1$23

Products named: COBENFY, ABILIFY MAINTENA, VRAYLAR, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, TRINTELLIX.

Industry payments across ID — which companies pay providers there.